{"id":"https://openalex.org/W2947396154","doi":null,"title":"The \u2018dark side\u2019 of tamoxifen: understanding adverse cellular response to endocrine therapy in ER+ breast cancer","display_name":"The \u2018dark side\u2019 of tamoxifen: understanding adverse cellular response to endocrine therapy in ER+ breast cancer","publication_year":2019,"publication_date":"2019-01-01","ids":{"openalex":"https://openalex.org/W2947396154","mag":"2947396154"},"language":"en","primary_location":{"id":"pmh:oai:https://orca.cardiff.ac.uk:123021","doi":null,"is_oa":false,"landing_page_url":"https://orca.cardiff.ac.uk/id/eprint/123021/9/2019ReesM%20MD.pdf","pdf_url":"https://orca.cardiff.ac.uk/id/eprint/123021/9/2019ReesM%20MD.pdf","source":{"id":"https://openalex.org/S4306401195","display_name":"ORCA Online Research @Cardiff (Cardiff University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79510175","host_organization_name":"Cardiff University","host_organization_lineage":["https://openalex.org/I79510175"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Thesis"},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111490520","display_name":"Michael Rees","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Michael Rees","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5111490520"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.9711999893188477,"subfield":{"id":"https://openalex.org/subfields/1310","display_name":"Endocrinology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.9711999893188477,"subfield":{"id":"https://openalex.org/subfields/1310","display_name":"Endocrinology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.022199999541044235,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tamoxifen","display_name":"tamoxifen","score":0.9819999933242798},{"id":"https://openalex.org/keywords/fulvestrant","display_name":"fulvestrant","score":0.9070000052452087},{"id":"https://openalex.org/keywords/estrogen-receptor-positive-breast-cancer","display_name":"estrogen receptor-positive breast cancer","score":0.7850000262260437},{"id":"https://openalex.org/keywords/endocrine-resistance","display_name":"endocrine therapy resistance","score":0.7799999713897705},{"id":"https://openalex.org/keywords/breast-cancer-cell-invasion","display_name":"breast cancer cell invasion","score":0.6190000176429749},{"id":"https://openalex.org/keywords/cell-migration","display_name":"cell migration","score":0.968999981880188},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.8769999742507935},{"id":"https://openalex.org/keywords/aromatase-inhibitors","display_name":"aromatase inhibitors","score":0.9580000042915344},{"id":"https://openalex.org/keywords/mcf-7-cells","display_name":"MCF-7 cells","score":0.8519999980926514},{"id":"https://openalex.org/keywords/3d-culture-models","display_name":"3D culture models","score":0.6909999847412109},{"id":"https://openalex.org/keywords/treatment-response-biomarkers","display_name":"treatment response biomarkers","score":0.5910000205039978}],"concepts":[{"id":"https://openalex.org/C2780482068","wikidata":"https://www.wikidata.org/wiki/Q5508491","display_name":"Fulvestrant","level":5,"score":0.786253809928894},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.6721799969673157},{"id":"https://openalex.org/C46699223","wikidata":"https://www.wikidata.org/wiki/Q11078","display_name":"Endocrine system","level":3,"score":0.659375786781311},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.6021556854248047},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5830851197242737},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4840180575847626},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.43647754192352295},{"id":"https://openalex.org/C2777164284","wikidata":"https://www.wikidata.org/wiki/Q277954","display_name":"Estrogen","level":2,"score":0.4353170096874237},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43442240357398987},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4292331039905548},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.38298776745796204},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.35588178038597107},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.33538317680358887},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.10690754652023315}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:https://orca.cardiff.ac.uk:123021","doi":null,"is_oa":false,"landing_page_url":"https://orca.cardiff.ac.uk/id/eprint/123021/9/2019ReesM%20MD.pdf","pdf_url":"https://orca.cardiff.ac.uk/id/eprint/123021/9/2019ReesM%20MD.pdf","source":{"id":"https://openalex.org/S4306401195","display_name":"ORCA Online Research @Cardiff (Cardiff University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79510175","host_organization_name":"Cardiff University","host_organization_lineage":["https://openalex.org/I79510175"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Thesis"},{"id":"mag:2947396154","doi":null,"is_oa":false,"landing_page_url":"https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.775022","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3009610879","https://openalex.org/W2885857510","https://openalex.org/W3118111915","https://openalex.org/W2334182653","https://openalex.org/W2115387040","https://openalex.org/W2560980306","https://openalex.org/W2057245090","https://openalex.org/W2420560209","https://openalex.org/W151573580","https://openalex.org/W4283258653"],"abstract_inverted_index":{"Background:":[0],"Endocrine":[1],"resistance":[2],"is":[3,58],"a":[4,34,75,165,174,193,290],"common":[5],"problem":[6],"in":[7,15,42,73,84,89,116,168,184,192,206,214,220,226,243,257,296],"estrogen":[8],"receptor":[9],"positive":[10],"(ER+)":[11],"breast":[12,96,245],"cancer,":[13],"particularly":[14,41],"the":[16,20,43,49,106,117,185],"advanced":[17],"setting.":[18],"Beyond":[19],"anticipated":[21],"effects":[22,50,101],"of":[23,45,51,71,102,111,121,152,178,187],"endocrine":[24,39,56,79,103],"resistance,":[25],"recent":[26],"evidence":[27],"points":[28],"towards":[29],"some":[30],"ER+":[31,112,169,244,297],"cancers":[32,246],"exhibiting":[33],"counterintuitive,":[35],"adverse":[36,52,199,240],"response":[37,54,77,293],"to":[38,55,69,78,86,93,275,294],"treatments,":[40,80],"setting":[44,186],"E-cadherin":[46,123,262],"deficiency.":[47],"Here":[48],"cell":[53,129,153,241],"therapy":[57],"explored,":[59],"including":[60],"responsible":[61,236],"cellular":[62],"mechanisms.":[63],"The":[64,100],"ER":[65],"co-receptor":[66],"PELP-1,":[67,125],"found":[68],"be":[70,235,254,280],"importance":[72],"mediating":[74],"pro-invasive":[76],"was":[81,182,201],"further":[82],"explored":[83],"relation":[85],"its":[87],"function":[88],"ER+,":[90],"as":[91,273,289],"compared":[92],"triple":[94],"negative":[95],"cancer":[97],"(TNBC).":[98],"\\nMethods:":[99],"treatments":[104],"on":[105,149],"proliferative":[107],"and":[108,113,131,162,190,228,287,298],"invasive/migratory":[109],"capacity":[110],"TNBC":[114,138,221],"cells,":[115,139,216],"presence":[118],"or":[119],"absence":[120],"functional":[122],"and/or":[124],"were":[126,141,155],"determined":[127,156],"using":[128],"counting":[130],"trans-well":[132],"Boyden":[133],"chamber-based":[134],"assays":[135],"respectively.":[136],"For":[137],"studies":[140,148],"extended":[142],"into":[143],"3D":[144,229],"culture":[145],"models.":[146],"Mechanistic":[147],"endocrine-mediated":[150],"modulation":[151],"signalling":[154],"by":[157],"Western":[158],"blotting.":[159],"\\nResults:":[160],"Tamoxifen":[161],"fulvestrant":[163],"induced":[164],"pro-invasive/pro-migratory":[166],"phenotype":[167,200,242],"MCF-7":[170,215],"cells":[171,204,222],"that":[172,247,259],"displayed":[173],"high":[175],"basal":[176],"expression":[177],"PELP-1.":[179],"This":[180],"effect":[181,252],"augmented":[183],"E-Cadherin":[188],"suppression":[189,210],"regulated":[191],"Src-dependent":[194],"manner.":[195],"In":[196],"contrast,":[197],"no":[198],"observed":[202],"with":[203,270],"cultured":[205],"estrogen-deprived":[207],"conditions.":[208],"PELP-1":[209,218,278],"reduced":[211],"endocrine-induced":[212],"invasion/migration":[213],"whilst":[217],"knockdown":[219],"inhibited":[223],"endogenous":[224],"invasion":[225],"2D":[227],"culture.":[230],"\\nConclusion:":[231],"ER-targeting":[232,276],"anti-estrogens":[233],"may":[234,253,266,279],"for":[237,284],"inducing":[238],"an":[239,281],"highly":[248],"express":[249],"PELP-1;":[250],"this":[251],"more":[255],"apparent":[256],"tumours":[258,265],"are":[260],"also":[261],"deficient.":[263],"Such":[264],"benefit":[267],"from":[268],"treatment":[269,295],"aromatase":[271],"inhibitors":[272],"opposed":[274],"agents.":[277],"important":[282],"target":[283],"future":[285],"therapy,":[286],"act":[288],"biomarker,":[291],"predicting":[292],"TNBC.":[299]},"counts_by_year":[],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2019-06-07T00:00:00"}